DXCM 69.55 (-0.5%)
US2521311074Medical Diagnostics & ResearchDiagnostics & Research

DexCom (DXCM) Competitor Comparison

We are evaluating the key criteria listed to compare DexCom (DXCM) against its competitors in the Diagnostics & Research industry.

Linearity 5 years - DXCM ranking 18 / 58

These are the competitors of DexCom in the industry Diagnostics & Research ranked by linearity 5 years
1. Co-Diagnostics CODX
57.28
2. Ortho Clinical Diagnostics Holdings OCDX
33.4
3. DarioHealth DRIO
31.71
4. Syneos Health SYNH
24.79
5. Heska HSKA
15.42
6. CareDx CDNA
14.3
7. Anixa Biosciences ANIX
11.8
8. Inotiv NOTV
11.49
9. Fulgent Genetics FLGT
9.21
10. Olink Holding OLK
8.53
11. NeoGenomics NEO
8.32
12. Charles River Laboratories CRL
7.72
13. Trinity Biotech TRIB
7.45
14. Myriad Genetics MYGN
7.12
15. Pacific Biosciences of California PACB
7.09
16. Exact Sciences EXAS
6.65
17. Aspira Womens Health AWH
5.9
18. DexCom DXCM
5.72
19. Twist Bioscience TWST
5.66
20. Quest Diagnostics DGX
5.12
21. Qiagen QGEN
5.11
22. PerkinElmer PKI
4.97
23. Laboratory Corp of America Holdings LH
4.88
24. Illumina ILMN
4.33
25. Sotera Health SHC
4.16
26. Personalis PSNL
3.92
27. Neogen NEOG
3.92
28. Guardant Health GH
3.87
29. IDEXX Laboratories IDXX
3.82
30. IQVIA Holdings IQV
3.74
31. National Research NRC
3.37
32. Waters WAT
3.24
33. Enzo Biochem ENZ
3.15
34. Bioventus BVS
3.1
35. Sera Prognostics SERA
2.88
36. Agilent Technologies A
2.69
37. Exagen XGN
2.61
38. Psychemedics PMD
2.56
39. Precipio PRPO
2.33
40. Interpace Biosciences IDXG
2.31
41. Neuronetics STIM
2.28
42. Thermo Fisher Scientific TMO
2.24
43. Global Cord Blood CO
2.23
44. Mettler-Toledo MTD
2.17
45. MaxCyte MXCT
2.07
46. Danaher DHR
2.04
47. MDxHealth MDXH
2.04
48. Icon ICLR
1.98
49. Biodesix BDSX
1.97
50. Prenetics Global PRE
1.82
51. bioAffinity Technologies BIAF
1.65
52. Organovo Holdings ONVO
1.6
53. SeqLL SQL
1.38
54. Meridian Bioscience VIVO
0.99
55. Natera NTRA
0.78
56. Medpace Holdings MEDP
0.5
57. RadNet RDNT
0.38
58. Lantheus Holdings LNTH
0.25

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.